SEC Tracker
Get the app

Vaxcyte PCVX

Vaxcyte raises $575M via convertible notes

Form
8-K
Filed
Importance
Notable
  1. Raised $575M through 1.50% Convertible Senior Notes due 2032
  2. Notes mature on October 15, 2032
  3. Conversion rate of 11.1607 shares per $1,000 principal
  4. Equity offering raised $544.3M after expenses

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Vaxcyte files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. PERRIGO PRGO public float $3.7B, Jun 27, 2025
  2. Rhythm Pharmaceuticals RYTM public float $3.8B, Jun 30, 2025
  3. Ultragenyx Pharmaceutical RARE public float $3.4B, Jun 30, 2025
  4. Avidity Biosciences RNAM public float $3.4B, Jun 30, 2025
  5. Soleno Therapeutics SLNO public float $4.1B, Jun 30, 2025